Health secretary Alan Johnson’s announcement last month on new government guidance regarding medicines for NHS patients, following the landmark review by national cancer director Professor Mike Richards CBE, has finally given the green light for insurers to develop new top-up policies.Although Bupa is yet to announce whether it will be entering this newly emerging market,…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
